James Karrels
2023
In 2023, James Karrels earned a total compensation of $1.6M as Senior Vice President, Chief Financial Officer and Corporate Secretary at MacroGenics, a 5% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $209,000 |
---|---|
Option Awards | $668,538 |
Salary | $471,106 |
Stock Awards | $216,900 |
Other | $13,200 |
Total | $1,578,744 |
Karrels received $668.5K in option awards, accounting for 42% of the total pay in 2023.
Karrels also received $209K in non-equity incentive plan, $471.1K in salary, $216.9K in stock awards and $13.2K in other compensation.
Rankings
In 2023, James Karrels' compensation ranked 754th out of 3,006 executives tracked by ExecPay. In other words, Karrels earned more than 74.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 754 out of 3,006 | 75th |
Division Manufacturing | 433 out of 1,650 | 74th |
Major group Chemicals And Allied Products | 295 out of 918 | 68th |
Industry group Drugs | 289 out of 881 | 67th |
Industry Pharmaceutical Preparations | 190 out of 637 | 70th |
Source: SEC filing on April 8, 2024.
Karrels' colleagues
We found two more compensation records of executives who worked with James Karrels at MacroGenics in 2023.
News
MacroGenics CEO Scott Koenig's 2023 pay slips 20% to $3.7M
April 8, 2024
MacroGenics CEO Scott Koenig's 2022 pay slips 5% to $4.6M
April 17, 2023
MacroGenics CEO Scott Koenig's 2021 pay jumps 56% to $4.9M
April 8, 2022
MacroGenics Chief Medical Officer Stephen Eck receives $5.1M in 2020
April 1, 2021
MacroGenics CEO Scott Koenig's 2019 pay slips 9% to $4.7M
April 2, 2020